Published in Nat Med on August 01, 1995
Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet (2008) 6.10
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc Natl Acad Sci U S A (1997) 2.54
Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell (2009) 2.10
Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet (2001) 2.03
Evidence for a prostate cancer-susceptibility locus on chromosome 20. Am J Hum Genet (2000) 1.69
Prostate cancer: 3. Individual risk factors. CMAJ (1998) 1.66
Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet (2000) 1.64
Fatherhood and incident prostate cancer in a prospective US cohort. Int J Epidemiol (2010) 1.63
Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting. Am J Hum Genet (1998) 1.63
Evidence for autosomal dominant inheritance of prostate cancer. Am J Hum Genet (1998) 1.63
Genetics of prostate cancer: too many loci, too few genes. Am J Hum Genet (2000) 1.58
A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet (2000) 1.51
Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer (2001) 1.44
Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators. Am J Hum Genet (1998) 1.35
Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. Am J Hum Genet (2001) 1.32
Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer. Am J Hum Genet (1999) 1.30
An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysis. PLoS One (2011) 1.30
In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancer. Am J Hum Genet (1999) 1.10
A genomic scan of families with prostate cancer identifies multiple regions of interest. Am J Hum Genet (2000) 1.05
Molecular mechanisms involving prostate cancer racial disparity. Am J Transl Res (2009) 1.02
Genetic polymorphisms and prostate cancer risk. World J Urol (2003) 0.96
Genome-wide linkage scan for prostate cancer susceptibility genes in men with aggressive disease: significant evidence for linkage at chromosome 15q12. Hum Genet (2006) 0.96
Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci. Br J Cancer (2004) 0.94
CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk. Br J Cancer (1999) 0.93
Segregation analyses of 1,476 population-based Australian families affected by prostate cancer. Am J Hum Genet (2001) 0.93
Molecular pathways in prostate cancer. Nephrourol Mon (2013) 0.92
X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity. Trends Genet (2010) 0.90
Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance. Hum Genet (2007) 0.84
Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer. Am J Hum Genet (2001) 0.83
Male reproductive health and prostate cancer risk. Curr Opin Urol (2011) 0.81
Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility. Evol Appl (2012) 0.78
Molecular basis for prostate cancer racial disparities. Front Biosci (Landmark Ed) (2017) 0.78
Estimation of sibling recurrence-risk ratio under single ascertainment in two-child families. Am J Hum Genet (2001) 0.75
Is race an independent prognostic factor for survival from prostate cancer? J Natl Med Assoc (1998) 0.75
Androgen receptor and familial prostate cancer. Nat Med (1995) 0.75
The clinical genetics of prostate cancer. Hered Cancer Clin Pract (2004) 0.75
A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol (2000) 13.17
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science (1990) 4.80
A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev (1994) 4.62
Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol (2000) 4.46
Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet (1983) 4.38
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet (1992) 4.11
Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study. JAMA (1996) 3.77
Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire. Nutr Cancer (2001) 3.77
Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst (1995) 3.67
Estrogens and endometrial cancer in a retirement community. N Engl J Med (1976) 3.64
'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature (1983) 3.63
A spontaneous lower motor neuron disease apparently caused by indigenous type-C RNA virus in wild mice. J Natl Cancer Inst (1973) 3.59
Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Risk factors for cancer of the testis in young men. Int J Cancer (1979) 3.42
Increased cell division as a cause of human cancer. Cancer Res (1990) 3.38
Endogenous hormones as a major factor in human cancer. Cancer Res (1982) 3.30
Endogenous hormones and breast cancer risk. Epidemiol Rev (1993) 3.27
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer (1991) 3.14
Gender- and smoking-related bladder cancer risk. J Natl Cancer Inst (2001) 3.05
Physical exercise and reduced risk of breast cancer in young women. J Natl Cancer Inst (1994) 2.93
Oral contraceptive use and early abortion as risk factors for breast cancer in young women. Br J Cancer (1981) 2.89
Aspirin use and chronic diseases: a cohort study of the elderly. BMJ (1989) 2.89
Reliability of recall of drug usage and other health-related information. Am J Epidemiol (1982) 2.81
Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor. J Natl Cancer Inst (1997) 2.74
Agreement between interview information and physician records on history of menopausal estrogen use. Am J Epidemiol (1990) 2.71
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Circumcision and human papillomavirus infection in men: a site-specific comparison. J Infect Dis (2008) 2.58
The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol (2011) 2.54
Cancer incidence in the Mexican-American. J Natl Cancer Inst (1975) 2.54
De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci U S A (1990) 2.42
Toward the primary prevention of cancer. Science (1991) 2.41
Stage and delay in breast cancer diagnosis by race, socioeconomic status, age and year. Br J Cancer (1992) 2.40
Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer (1979) 2.39
Use of permanent hair dyes and bladder-cancer risk. Int J Cancer (2001) 2.36
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China. Cancer Res (1989) 2.35
Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst (1983) 2.34
A multipurpose serological survey in Kenya. 2. Results of arbovirus serological tests. Bull World Health Organ (1970) 2.34
Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis (2000) 2.29
Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology (1994) 2.26
Decreased mortality in users of estrogen replacement therapy. Arch Intern Med (1991) 2.26
Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition. J Biol Chem (1986) 2.25
A prospective study of pancreatic cancer in the elderly. Int J Cancer (1994) 2.25
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Epidemiology of soy exposures and breast cancer risk. Br J Cancer (2008) 2.22
Occupational differences in rates of lung cancer. J Occup Med (1976) 2.19
"Incessant ovulation" and ovarian cancer. Lancet (1979) 2.18
A case-control study of menopausal estrogen therapy and breast cancer. JAMA (1980) 2.15
An epidemiologic study of breast cancer. J Natl Cancer Inst (1974) 2.15
Estrogens and breast cancer. Carcinogenesis (1996) 2.15
Menopausal estrogen therapy and hip fractures. Ann Intern Med (1981) 2.13
Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J (Clin Res Ed) (1986) 2.08
Associations of sedentary lifestyle, obesity, smoking, alcohol use, and diabetes with the risk of colorectal cancer. Cancer Res (1997) 2.06
Stroke prevention and oestrogen replacement therapy. Lancet (1989) 2.05
Follow up study of moderate alcohol intake and mortality among middle aged men in Shanghai, China. BMJ (1997) 2.05
Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol (1995) 2.04
The growing importance of California arboviruses in the etiology of human disease. Prog Med Virol (1971) 2.04
Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol (1993) 2.04
The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer. Oncology (Williston Park) (1990) 2.04
Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol (1995) 2.02
Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol (2001) 2.02
Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomarkers Prev (1998) 2.00
Urogenital tract abnormalities in sons of women treated with diethylstilbestrol. Pediatrics (1976) 2.00